AstraZeneca Says Its COVID-19 Vaccine Is Safe, Despite Reports of Deadly Clots
MONDAY, March 15, 2021 -- There is no scientific evidence linking the AstraZeneca COVID-19 vaccine to recent deaths from blood clots, the company said Sunday after a number of European nations suspended use of the vaccine.
On Sunday, Ireland and the Netherlands joined at least 10 other countries in suspending use of the vaccine -- either disposing of specific batches or halting all shots with the product -- as a precautionary measure while public health authorities investigate the blood clot deaths or other "thrombotic events," the Washington Post reported. In a statement, AstraZeneca said 17 million people have so far received its vaccine and there have only been 15 cases of deep vein thrombosis and 22 pulmonary embolisms.
"This is much lower than would be expected to occur naturally in a general population of this size and is similar across other licensed COVID-19 vaccines," the company said. It also said that the number of thrombotic events in the vaccine's clinical trials was actually "lower in the vaccinated group."
"The nature of the pandemic has led to increased attention in individual cases and we are going beyond the standard practices for safety monitoring of licensed medicines in reporting vaccine events, to ensure public safety," AstraZeneca Chief Medical Officer Ann Taylor, M.D., said, The Post reported.
The AstraZeneca vaccine, which was developed with researchers from Oxford University, has been heavily used in Britain, which is leading Europe's immunization efforts, The Post said.
© 2021 HealthDay. All rights reserved.
Posted: March 2021
Further Support and Information on COVID-19
Read this next
FRIDAY, April 16, 2021 -- For persons with a history of previous infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the neutralizing antibody titer is...
FRIDAY, April 16, 2021 -- Vaccinated Americans will probably need booster shots to guard against emerging coronavirus variants in the future, a White House adviser and Pfizer said...
FRIDAY, April 16, 2021 -- COVID-19 ups the risk for death with hemorrhagic stroke by more than twofold, according to a study published online April 14 in PLOS ONE. Vijay M....
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.